🔗 Share this article

This year's prestigious award in medical science was awarded for transformative findings that clarify how the body's defense network targets dangerous infections while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this honor.

The work identified specialized "sentinels" within the immune system that remove rogue defense cells capable of harming the body.

These discoveries are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These laureates will share a monetary award valued at 11m SEK.

Decisive Discoveries

"Their research has been decisive for comprehending how the body's defenses functions and why we don't all develop serious autoimmune diseases," stated the head of the award panel.

This team's studies address a core question: In what way does the immune system protect us from numerous invaders while leaving our own tissues unharmed?

The body's protection system employs immune cells that scan for indicators of infection, even pathogens and bacteria it has not met before.

Such defenders employ detectors—called recognition units—that are generated by chance in a vast number of variations.

That provides the defense network the ability to fight a wide array of invaders, but the unpredictability of the process inevitably produces immune cells that may attack the host.

Protectors of the Immune System

Scientists previously knew that some of these harmful defense cells were destroyed in the immune organ—where immune cells develop.

This year's Nobel Prize honors the discovery of T-reg cells—described as the immune system's "peacekeepers"—which patrol the system to neutralize other immune cells that assault the healthy cells.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

A prize committee added, "The discoveries have laid the foundation for a novel area of investigation and accelerated the development of innovative treatments, for example for tumors and autoimmune diseases."

In malignancies, T-regs prevent the body from attacking the tumor, so research are aimed at lowering their numbers.

For autoimmune diseases, trials are exploring increasing regulatory T-cells so the organism is no longer being harmed. A similar approach could also be effective in reducing the chances of organ transplant rejection.

Innovative Studies

Professor Sakaguchi, of Osaka University, performed tests on rodents that had their immune gland extracted, causing autoimmune disease.

The researcher demonstrated that injecting defense cells from healthy animals could stop the illness—suggesting there was a mechanism for blocking defenders from harming the body.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in rodents and humans that resulted in the identification of a gene critical for the way regulatory T-cells function.

"Their pioneering research has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly attacking the healthy cells," commented a prominent physiology specialist.

"The work is a remarkable example of how fundamental physiological study can have broad implications for human health."